Improving colorectal cancer screening for diabetes patients in safety-net clinics
Optimizing Colorectal Cancer Screening Among Patients With Diabetes in Safety-Net Primary Care Settings: Targeting Implementation Approaches
This study is testing a new approach to improve colorectal cancer screening for diabetes patients in community clinics by using education, reminders, and training for doctors to see if it helps more people get screened.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 50 Years to 74 Years |
| Sex | All |
| Sponsor | Rutgers, The State University of New Jersey Academic / other |
| Locations | 1 site (New Brunswick, New Jersey) |
| Trial ID | NCT05785780 on ClinicalTrials.gov |
What this trial studies
This study evaluates a multi-level intervention aimed at enhancing colorectal cancer (CRC) screening among patients with diabetes in primary care safety-net settings. It employs a hybrid effectiveness-implementation design across six clinics, focusing on both the effectiveness of the intervention and its feasibility. The intervention includes strategies such as patient education, reminders, and clinician training, developed through community engagement. The study will assess the impact of these strategies on CRC screening rates and implementation factors over a 12-month period.
Who should consider this trial
Good fit: Ideal candidates are adults aged 50-74 with diabetes who are not up-to-date with CRC screening.
Not a fit: Patients with prior colorectal cancer diagnoses or other medical conditions that contraindicate standard CRC screening will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly improve CRC screening rates among diabetes patients, leading to earlier detection and better health outcomes.
How similar studies have performed: Other studies have shown success in implementing targeted interventions for CRC screening, indicating that this approach has potential based on prior evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of diabetes mellitus; * Participants not up-to-date with CRC screening based on electronic health record (e.g. FOBT/FIT in last year; flexible sigmoidoscopy within four years; or colonoscopy within nine years); * Age-eligible for CRC screening (50-74 years of age); * Participants in process of undergoing screening are eligible for participation if they have a FIT/FOBT incomplete test ordered for more than six months or a sigmoidoscopy or colonoscopy referral not completed for greater than one year. Exclusion Criteria: • Medical conditions not concordant with standard CRC screening intervals (e.g. prior CRC diagnosis, inflammatory bowel disease, renal failure, etc.).
Where this trial is running
New Brunswick, New Jersey
- RWJBarnabas Health - Robert Wood Johnson University Hospital — New Brunswick, New Jersey, United States (Recruiting)
Study contacts
- Principal investigator: Denalee O'Malley, PhD — Rutgers Robert Wood Johnson Medical School; Rutgers Cancer Institute of New Jersey
- Study coordinator: Denalee O'Malley, PhD
- Email: omalledm@rwjms.rutgers.edu
- Phone: 848-319-0004
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.